Shares of Albemarle Co. (NYSE:ALB - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $104.03, but opened at $107.00. Albemarle shares last traded at $104.72, with a volume of 242,616 shares traded.
ALB has been the subject of a number of research reports. Piper Sandler lowered their target price on Albemarle from $95.00 to $90.00 and set an "underweight" rating for the company in a research report on Thursday, August 8th. Berenberg Bank cut shares of Albemarle from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $160.00 to $83.00 in a research note on Wednesday, July 31st. Wells Fargo & Company increased their price target on shares of Albemarle from $100.00 to $110.00 and gave the company an "equal weight" rating in a report on Tuesday, October 8th. JPMorgan Chase & Co. reduced their price objective on Albemarle from $115.00 to $78.00 and set a "neutral" rating on the stock in a research note on Monday, August 19th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on Albemarle from $105.00 to $80.00 and set a "hold" rating for the company in a research note on Friday, August 16th. One research analyst has rated the stock with a sell rating, fifteen have given a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $114.47.
Read Our Latest Research Report on Albemarle
The firm has a market cap of $12.36 billion, a P/E ratio of -6.21 and a beta of 1.55. The company has a current ratio of 2.44, a quick ratio of 1.58 and a debt-to-equity ratio of 0.43. The firm has a 50-day simple moving average of $96.03 and a 200-day simple moving average of $99.64.
The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, December 13th will be issued a $0.405 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $1.62 dividend on an annualized basis and a yield of 1.54%. Albemarle's dividend payout ratio is presently -9.67%.
A number of institutional investors and hedge funds have recently modified their holdings of ALB. Empowered Funds LLC acquired a new position in shares of Albemarle during the first quarter worth $202,000. Blair William & Co. IL boosted its holdings in Albemarle by 40.2% in the first quarter. Blair William & Co. IL now owns 5,645 shares of the specialty chemicals company's stock worth $744,000 after acquiring an additional 1,620 shares in the last quarter. O Shaughnessy Asset Management LLC grew its stake in shares of Albemarle by 40.6% during the first quarter. O Shaughnessy Asset Management LLC now owns 1,973 shares of the specialty chemicals company's stock worth $260,000 after acquiring an additional 570 shares during the last quarter. UniSuper Management Pty Ltd increased its holdings in shares of Albemarle by 544.9% during the first quarter. UniSuper Management Pty Ltd now owns 9,151 shares of the specialty chemicals company's stock valued at $1,206,000 after acquiring an additional 7,732 shares in the last quarter. Finally, Bessemer Group Inc. raised its position in shares of Albemarle by 116.1% in the 1st quarter. Bessemer Group Inc. now owns 1,759 shares of the specialty chemicals company's stock valued at $232,000 after purchasing an additional 945 shares during the last quarter. Hedge funds and other institutional investors own 92.87% of the company's stock.
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.